Major Cancer Biology Students 2016

17. October 2016: Welcome to our new students - "10 years of Major Cancer Biology"!

© dkfz.de

Fabienne AMRHEIN (Germany)

© dkfz.de

University Education
10/2013 – 09/2016 Bachelor of Science (Biochemistry) Ruprecht-Karls-University Heidelberg, Germany
09/2015 – 12/2015 ERASMUS semester at Oxford Brookes University, Oxford, UK
08/2012 – 07/2013 Bachelor of Science (Major Psychology) Mississippi State University, USA (full academic and sports scholarship)

Highest Degree
Bachelor of Science (Biochemistry)

Title of Bachelor Thesis
Establishing a Highly Flexible and Sensitive Method for Surface Antigen Detection on Single Cells​

Internships
01/2016 – 07/2016 “Establishing a Highly Flexible and Sensitive Method for Surface Antigen Detection on Single Cells” (Bachelor Thesis), Merten Group, European Molecular Biology Laboratory (EMBL), Germany
09/2014 – 10/2014 “Molecular mechanisms of coated vesicle formation”, Wieland Group, Heidelberg University Biochemistry Center (BZH), Germany

Research Interest/Future Plans
Cancer is a highly complex and unique phenomenon as a few cells begin to turn against their own organism harming the whole system critically. After many years of intensive research and great advances in treatment, a lot is still unknown about immunological and genetic mechanisms leading to cancer. Viruses are known to contribute to the development of cancer and studied as tools in therapeutic strategies. The field of research concerning oncolytic viruses shows high potential for future investigations. I chose the Master programme at the DKFZ to improve my scientific knowledge and skills and to gain a deeper understanding of how external and internal factors influence the organism leading to cancer. Learning how to treat cancer is a multidisciplinary challenge including not only scientific, but also industrial, economic and political institutions. After achievement of the Master degree I will join a PhD programme to contribute to the ultimate idea of being able to cure and maybe even prevent cancer one day.

Contact
f.amrhein (at) dkfz.de

Daniela AVILES HUERTA (Mexico)

© dkfz.de

University Education
10/ 2016 - present: Ruprecht-Karls-Universität Heidelberg and German Cancer Research Center (DKFZ, Heidelberg), MSc. Molecular Biosciences, Major Cancer Biology
08/2011 - 05/2016: Universidad Nacional Autónoma de México, Faculty of Chemistry (UNAM, Mexico)

Highest Degree 
BSc. Pharmaceutical and Biological Chemistry

Title of Bachelor Thesis
Development of selective disrupting peptides of Protein phosphatase 1

Traineeships
02/2016 - 06/2016: European Molecular Biology Laboratory (EMBL, Heidelberg). Genome Biology Unit, Chemical Biologist
06/2015 - 08/2015: DKFZ, Division of Genome Modifications and Carcinogenesis, Internship in Multiplex serology
05/2013 - 08/2013: UNAM, Faculty of Chemistry. Laboratory of Reproductive Biology, Internship in Epigenetics

Work Experience
11/2017 - 11/2018: European Molecular Biology Organization (EMBO, Heidelberg). EMBO Communications

Research Interests/Future Plans
As a chemist with an academic background focused on pharmacy, drug design and molecular biology, my scientific interests reside in the development of new therapies to treat cancer and elucidating the related molecular mechanisms. During this study program I aim to deepen my understanding in several fields such as Translational Cancer Research, particularly focused in Cancer Drug Development and Molecular Oncology.

Contact
d.aviles-huerta (at) dkfz.de

Pavle BOŠKOVIĆ (Serbia)

© dkfz.de

University Education
2012-2016: University of Belgrade, Faculty of Biology, Module of Molecular Biology and Physiology
2016-present: University of Heidelberg, Master Molecular BIoscience, major Cancer Biology

Highest Degree
B. Sc. of Biology, Molecular Biology and Physiology

Title of Bachelor Thesis

Internships
summer of 2011: Summer internship at Karolinska Institute, Stockholm, Division of Medical Biochemistry and Biophysics, Vascular Biology group, Project: research related to black-cell melanoma angiogenesis and its dependence on pericyte recruitment and attachment in a mouse model.

Future Plans
After I complete my Master's degree at the University of Heidelberg and DKFZ I would like to pursue a PhD in the subject of Cancer Biology, or more specifically tumor immunology. It is my belief that immunological treatment of tumors is the most perspective method to-date, possibly in the form of personalized medicine and target treatments. Working in a group which focuses on these subject areas is my current future plan.

Contact
p.boskovic (at) dkfz.de

Margherita D'ERRICO (Italy)

© dkfz.de

University Education
10/ 2016 - present: M.Sc. Molecular Biosciences (Major Cancer Biology), Ruprecht-Karls-Universität Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany
10/2013 - 07/2016: B.Sc. Biological Sciences (Major in Molecular Biology and Genetics), “La Sapienza” University of Rome, Italy
 
Highest Degree
B.Sc. Biological Sciences with Major in Molecular Biology and Genetics (Highest Honors)
 
Title of Bachelor Thesis
Cloning, expression and purification of hemA gene from Acinetobacter baumannii
 
Internships
October 2015 - June 2016: internship in the Department of Biochemical Sciences “A. Rossi Fanelli”, University of Rome “La Sapienza” (supervisor Prof. R. Contestabile). Project: “Cloning, expression and purification of hemA gene from Acinetobacter baumannii
 
Research Interest/Future Plans
When we talk about cancer, we refer to a wide group of different diseases, as it can result in various scenarios, depending on the patient, his background and many other variables. This is one of the reasons why cancer remains, nowadays, a highly challenging research field. I am really interested in the high potential of using our own immune system to fight it, since it is the cells of the same organism that go out of control. I also developed a strong interest in the metabolic aspects of this disease, thanks to my biochemical studies background.
During my M.Sc. in Cancer Biology I aim to broaden my knowledge in the biology of cancer and in different treatments and therapies, in order to pursue a PhD.
 
Contact
m.derrico (at) dkfz.de

Cansu ERIŞ (Turkey)

© dkfz.de

University Education
10/2016 - present: Pursuing M.Sc. in “Molecular Biosciences with Major Cancer Biology”, Ruprecht–Karls–University Heidelberg and German Cancer Research Center (DKFZ), Germany
09/2011 - 06/2016: B.Sc. in “Molecular Biology, Genetics and Bioengineering”, Sabanci University, Turkey

Highest Degree
B.Sc. in Molecular Biology, Genetics and Bioengineering

Title of Bachelor Thesis
The Crosstalk between Autophagy and DNA Damage Response, and Their Effects on Cancer

Internships
09/2015 – 06/2016: Bachelor Thesis, “The Crosstalk between Autophagy and DNA Damage Response, and Their Effects on Cancer” at Dr. Devrim Gozuacik’s Lab, Sabanci University, Turkey
07/2015 – 09/2015: Summer Internship, “Cytogenetics and Advanced Molecular Tests” at Kocaeli University School of Medicine Department of Medical Genetics Lab, Turkey
09/2014 – 05/2015: Research Assistant, “Natural Killer Cell Based Immunotherapy in Cancer” at Dr. Tolga Sutlu’s Lab, Sabanci University, Turkey
09/2012 – 02/2013: Research Assistant, “Identifying Antibiotic Producer Soil Bacteria that Inhibit the Growth of Escherichia Coli” at Dr. Erdal Toprak’s Lab, Sabanci University, Turkey

Research Interest/Future Plan
During my undergraduate studies, I have always been fascinated by the self-sufficient characteristics of cancer cells as well as their ability to escape from intracellular control mechanisms including cell cycle checkpoint control and apoptosis to survive and proliferate. Thereby, I am particularly interested in the studies of molecular basis of the cancer cells and their relation to cell death mechanisms. With this regard, Major Cancer Biology Master Program of Bioscience provides an outstanding opportunity to receive professional training on the broad range of cancer research topics and state-of-the art techniques. Through completion of this program, I will be able to further deepen my knowledge in cancer biology both theoretically and practically to build a solid basis for my future career.

Contact
c.eris (at) dkfz.de

Yassin HARIM (Germany)

© dkfz.de

University Education
10/2016 - present: Master of Science (M.Sc.) in Molecular Biosciences with Major Cancer Biology at Heidelberg University and DKFZ in Heidelberg, Germany
10/2013 - 10/2016: Bachelor of Science (B.Sc.) in Biosciences at Heidelberg University, Germany
09/2012 - 07/2013: Bachelor of Science (B.Sc.) in Physics at Heidelberg University, Germany (2 semesters)

Highest Degree
Bachelor of Science (B.Sc.) in Biosciences

Title of Bachelor Thesis
The Chromatin Remodeler Chd7 is Required for Forebrain Development

Internships/Working Experience
10/2016 - present: Research assistant in the group of Dr. Liu, Molecular Neurogenetics, DKFZ, Heidelberg, Germany
06/2016 - 10/2016: Internship and bachelor thesis in the group of Dr. Liu, Molecular Neurogenetics, DKFZ, Heidelberg, Germany
07/2013 - 08/2013: Internship in the group of Prof. Pfeffer, Department of Biochemistry, Stanford University, USA
12/2010 – present: Student assistant and mentor at the Heidelberg Life-Science Lab at DKFZ, Heidelberg, Germany

Research Interest/Future Plans
Cancer is of great interest to me due to its very complex and diverse nature. I am fascinated by the various molecular mechanisms which allow cells to escape normal cell regulation and to develop into a tumour, as well as the different protection systems nature has evolved. Furthermore, I am deeply interested in the principles of modern cancer therapy, mostly the usage of viral vectors and immunotherapy to treat cancer. During my studies in the Major Cancer Biology at DKFZ, I want to gain extensive knowledge in such cutting-edge cancer research and its methods. I am sure that my studies at DKFZ will prepare me excellently for a PhD and a following career in cancer research to be able to contribute substantially to the fight against cancer during my work life. 

Contact
y.harim (at) dkfz.de

Anna HARTLEY (Australia & Germany)

© dkfz.de

University Education
2012 – 2015: Bachelor of Science (Advanced) at the University of Adelaide, South Australia
2013 – 2015: Diploma in Instrumental Music at the University of Adelaide, South Australia

Highest Degree
Bachelor of Science (Advanced) in Biochemistry and Microbiology and Immunology

Internships
Jul - Sep 2015: Placement at the University of Adelaide in the Jensen group (translational control at synapses by FMRP)
Mar - May 2015: Placement at the University of Adelaide in the McColl group (regulation of NK cell ligand expression by the atypical chemokine receptor CCX-CKR)
Jan - Feb 2015: Placement at the National Center for Tumor Diseases, Heidelberg in the Arndt/Krauss group (development of phage display technology in selecting antibodies for specific tumour therapies)
Jan - Feb 2014: Summer Scholarship at the University of Sydney in the Jolliffe group (synthesis of novel squaramide-based anion receptors)
Nov 2013 - Jan 2014: Summer Scholarship at the University of New South Wales in the Crossley group (regulation of γ- to β-globin switching in haemoglobin via transcription factor zBTB7a)
Dec 2012 - Jan 2013: Summer Scholarship at the University of Adelaide in the Carver group (dimeric structure of 14-3-3 protein, amyloid fibril formation in small heat-shock proteins)

Research Interests/Future Plans
I find cancer an innately interesting concept, as it has so many potential variations, and thereby many potential avenues for treatment. Emerging treatments such as immunotherapy also intrigue me, as they mark a development of a totally new basis for treating malignant diseases - and possibly other diseases as well. The discovery and ongoing characterisation of cancer stem cells also suggests an exciting possibility for effective treatment
of the disease with a decreased risk of relapse. I am also interested to follow the development of research techniques such as CRISPR/Cas genome engineering to allow more specific, more efficient research with a plethora of potential applications. I hope to develop my knowledge of such cutting edge research during my time at the DKFZ, and plan to pursue a PhD following my Masters.

Contact
a.hartley (at) dkfz.de

Aslihan INAL (Turkey)

© dkfz.de

University Education
10/2016 - Present: Ruprecht-Karls-University Heidelberg and German Cancer Research Center (DKFZ). MSc. Molecular Biosciences with Major Cancer Biology. (Heidelberg/GERMANY)
09/2010 - 07/2015: Istanbul Bilgi University, Faculty of Engineering and Natural Sciences, BSc Genetics and Bioengineering. (İstanbul/TURKEY)

Highest Degree
BSc. Genetics and Bioengineering

Title of Bachelor Thesis
Gene Expression Profile in High Risk Childhood Acute Lymphoblastic Leukemia During Diagnose, Relapse and Remission

Traineeships
09/2014 - 06/2015: Institute of Experimental Medicine, Istanbul University.
Worked on a project named as,“Epigenomic profile of Childhood Acute Lymphoblastic Leukemia(ALL) during Diagnosis, Complete Remission and Relapse” which my Senior Design Project is a part of it. Supervised by Yücel Erbilgin, PhD
06/2014 - 08/2014: International Centre for Genetic Engineering and Biotechnology(ICGEB)- Cellular Immunology Lab, (Cape Town, SOUTH AFRICA). Worked on a project "A rare L669S substitution in the Membrane Proximal External Region(MPER) of HIV-1 causes Enhanced Neutralization by MPER-specific and PG9/PG16-specific Antibodies", Supervised by Dr. Jeffrey Dorfman
09/2013 - 06/2014: İstanbul Bilgi University, (Istanbul, TURKEY) Student Assistant in General Chemistry, Organic Chemistry, Biochemistry, Biology, Microbiology, Genetics and Molecular Biology Labs
07/2013 - 09/2013: Institute of Oncology, Istanbul University, Cancer Research Lab. (Istanbul, TURKEY)
06/2013 - 07/2013: Abdi İbrahim Pharmaceuticals, Microbiology Lab. (Istanbul, TURKEY)

Research Interests/Future Plans
The atmosphere I breathe in and the places that I have been for improving myself caused everlasting interest for specifically Cancer Biology field and made me want to explore more. Complexity of this disease and how it is related with multiple topics appealed to me since I am not ready to settled for something so specific. Nevertheless, I know that I have been fascinated by the immunology already thanks to the times I have spent in the Cellular Immunology lab therefore I am keen to learn more about tumor immunology, and immunotherapy topics. I am excited to be just in the right place to learn more about cancer day by day and experiencing all the other exciting topics and new methods within Cancer Biology and be prepared to pursue PhD afterwards.

Contact
a.inal (at) dkfz.de

Victoria JENNINGS (Canada)

© dkfz.de

University Education
10.2016 – present: Masters in Molecular Biosciences (MSc) with a Major in Cancer Biology, Ruprecht-Karls-Universität Heidelberg and German Cancer Research Center (DKFZ), Germany
09.2012 – 04.2016: Bachelor of Science (BSc) with an Honors Specialization in Neuroscience, Western University, Canada

Highest Degree
Bachelor of Science (BSc) with an Honors Specialization in Neuroscience

Title of Bachelor Thesis
Expression of Pannexin 1 in Glioblastoma Multiforme

Internships
05.2016 – 07.2016: Summer research student in the division of Molecular Neurogenetics at the German Cancer Research Center (DKFZ), Germany
09.2015 – 04.2016 Bachelor Thesis project within the Department of Anatomy and Cell Biology and the Department of Clinical Neurological Sciences at Western University, Canada

Research Interest/Future Plans
I am fascinated by the complexity of cellular life and I am excited to further my knowledge of cell biology at the molecular level.  I am interested in understanding the molecular mechanisms involved in cancer development.  During my time at the DKFZ, I intend to further my understanding of stem cells, oncogenes and signal transduction as they relate to cell and tumour biology.  I am also excited to broaden my knowledge and learn about other topics relevant to cancer research, such as immunology, virology and epigenetics.  I am particularly interested in researching Glioblastoma Multiforme (GBM) and other tumours of the central nervous system, as it intersects my interests in neuroscience and cancer biology. 

Contact
v.jennings (at) dkfz.de

Anne JENSEIT (Germany)

© dkfz.de

University Education
10.2013 - 07.2016: Biomedical Science (B.Sc.) at Marburg University, Germany

Highest Degree
Bachelor of Science

Title of Bachelor Thesis
The influence of the p53-status on Cisplatin resistance and keratin expression in Head and Neck Squamous Cell Carcinoma

Internship
15.07.2015 - 29.09.2015: Research internship at the Penalva lab at University of Texas at San Antonio Health Science Center, San Antonio, Tx, USA

Research Interest
I have a very broad interest in the field of cancer research. Basic research and the idea to identify new mechanisms and pathways are as fascinating as more clinical and medical approaches. At the moment though, the fields of cancer stem cells and the way cancer cells manipulate and use their environment are most appealing.

Contact
a.jenseit (at) dkfz.de

Jonas KOEPPEL (Germany)

© dkfz.de

University Education
10/2016 - present: Master of Science in Molecular Biosciences with Major Cancer Biology at Ruprecht-Karls-University Heidelberg and DKFZ in Heidelberg, Germany
10/2013 - 10/2016: Bachelor of Science in Bioscience at Ruprecht-Karls-University Heidelberg

Highest Degree
Bachelor of Science (B.Sc.) in Biosciences

Title of Bachelor Thesis
Characterization of the chaperone network of Escherichia coli

Internships/Working Experience
04/2015 ­- 10/2016: Student assistant supervisor for the practical “Methods of Molecular Bio­science – part molecular biology” (PD Dr. S. Özbek)
11/2016 - present: Research assistant in the group of Prof. Bukau, ZMBH, Heidelberg, Germany (co-translational mechanisms of protein maturation)
07/2016 - present: Mentor for the high school team of the Heidelberg Life-Science Lab participating in the upcoming iGEM competition (2017)

Research Interest/Future Plans
With an estimate of over 1012 cells in the human body, how is it possible that we don’t develop cancer all the time? How does multicellular life strike the balance between self-renewal and cancer? How does this beautifully complex network of regulation and quality control, responsible for striking the balance, work in detail? These are just a fraction of questions I wish to learn more about during my M.Sc. in cancer biology. After finishing my master degree, I would very much like to do my PhD in cancer related basic science and follow the academic road. Research is an activity that will not become routine but instead drives you to acquire new concepts all lifelong, which is exactly the kind of profession I am aiming at.

Contact
j.koeppel (at) dkfz.de

Mohamed MAHMOUD (Egypt)

© dkfz.de

University Education
10/2016 - present: MSc. in Molecular Biosciences with major Cancer Biology, Ruprecht-Karls-Universität Heidelberg and DKFZ, Heidelberg, Germany
01/2016 - 04/2016: Molecular Biology Diploma, Egypt National Research Centre and SIRA Biotechnology Corp. Cairo, Egypt
09/2009 - 07/2014: BSc. in pharmaceutical sciences (Major clinical pharmacy), University of Tanta, College of Pharmacy, Egypt
 
Highest Degree
BSc. in pharmaceutical sciences (Major: clinical pharmacy), with highest honours
 
Internship/Research
03/2016 - 09/2016: provided a Research proposal (clinical study) to determine the effect of Sorfenib (TKI) on the survival rate in metastatic and non-metastatic osteosarcoma pediatric patients. “Children’s Cancer Hospital of Egypt 57357”, Cairo, Egypt
06/2013 - 08/2013: Summer Intern at the pharmaceutical services department "Tanta National Cancer Center". Tanta, Egypt
 
Research Interest/Future Plans
I am mostly captivated by the genuine relation that connects cancer and immune cells. Intelligent tumor cells can't only evade the immune components but also recruit them for their own welfare via secreting immunosuppressive cytokines or inhibitory cell surface proteins. On the other hand, we witness the failure of the immune surveillance with even losing the capability to present the tumor’s antigen, making immunoediting one of the most appealing research areas to pursue. My short-term aspiration is to build the skills required to pursue a PhD degree in the field of cancer treatment. One and only nagging question that lingers in my mind: is it possible to be part of a team that seeks finding an evolutionary targeted therapy to cancer? Research in the DKFZ will raise many relevant questions and I would like to be one of the people working towards the answers.
 
Contact
m.mahmoud (at) dkfz.de

Katharina MAUEL (Germany)

© dkfz.de

University Education
10/2016 - present: Ruprecht-Karls-Universität Heidelberg and German Cancer Research Center in Heidelberg (Germany) Molecular Biosciences with Major Cancer Biology
09/2013 - 08/2016: Hochschule Bonn-Rhein-Sieg in Rheinbach (Germany) Applied Biology
09/2015 - 06/2016: Robert Gordon University in Aberdeen (Scotland) Bioscience with Biomedical Sciences

Highest Degree
B.Sc. in Applied Biology
(Bachelor of Honors in Biomedical Sciences)

Title of Bachelor Thesis
Natural anticancer compounds and angiogenesis

Apprenticeship
08/2009 - 06/2012: center of advanced european studies and research (caesar) in Bonn (Germany) Chemical technical assistant

Work Experience
07/2012 - 09/2013: center of advanced european studies and research (caesar) in Bonn (Germany) Chemical technical assistant
07/2013 - 08/2013: Marine Biological Laboratory in Woods Hole (USA) Chemical technical assistant
10/2013 - 10/2014: center of advanced european studies and research in Bonn (Germany) Student assistant

Research Interests/Future Plans
I have a great interest in biology and medicine and my aim is it to do medical research and investigate and understand the molecular and cellular processes that cause diseases, especially cancer. I think it is most important to understand the various mechanisms that cause cancer as well as to develop effective treatment strategies in order to help the patients. With the study program of ‘molecular bioscience - cancer biology’ I want to deepen my knowledge about various key aspects of cancer research, including tumor immunology and virology. I hope to gain a profound insight into how to apply virology as a therapeutic strategy and how to target genetic alterations and signaling that lead to excessive cell proliferation and the formation of cancer, by practical experience in numerous DKFZ research groups. The DKFZ, with modern technologies and excellent scientists, enables me to be well prepared for my future career in cancer research.

Contact
k.mauel (at) dkfz.de

Tabea NIMZ (Germany)

© dkfz.de

University Ecuation
10/2016 – present: M.Sc. in Molecular Biosciences with Major Cancer Biology, Ruprecht-Karls-University Heidelberg, Germany
10/2012 –09/2016: B.Sc. in Biology, Georg-August-University Göttingen, Germany

Highest Degree
Bachelor of Science in Biology

Title of Bachelor Thesis
The role of Cyclin D1 and Cyclin D2 in prostate cancer

Internships
10/2015 – 11/2015: Internship at the Department of Plant Biology, Federal University of Viçosa, MG, Brazil; Group for Molecular Plant Physiology, Dr. Marcelo Rogalski
03/2015 – 08/2015: Bachelor thesis at the Institute of Human Genetics, Georg-August-University Göttingen, Germany; Prof. Dr. Peter Burfeind

Research Interest/Future Plans
What fascinates me about cancer research is that even though the many types of cancer share certain features to be classified as one kind of disease they are yet so different in terms of cause, course and hence treatment possibilities. Furthermore, the same type of cancer can vary individually in each patient, which is why I am especially interested in learning about personalized medicine. Nevertheless, I want to develop an understanding for all the key aspects of cancer including not only treatment possibilities but also causes and underlying mechanisms. I am confident that during this Master Program and possibly the following PhD Program the DKFZ will provide not only the theoretical knowledge but also the practical training in state of the art methods, as well as the networking possibilities to prepare me for my planned career in cancer research.

Contact
t.nimz (at) dkfz.de

Jyoti POKHAREL (Nepal)

© dkfz.de

University Education
10.2016 - present: Master of Science (M.Sc.) in Molecular Biosciences with Major Cancer Biology, Ruprecht-Karls-Universität Heidelberg and German Cancer Research Center (DKFZ), Germany
08.2010 - 05.2015: Bachelor of Science (B.Sc.) in Biological Sciences and Minor in Public Health, Asian University for Women, Chittagong, Bangladesh

Highest Degree
B.Sc. in Biological Sciences

Title of Bachelor Thesis
Mechanisms of Apoptosis Resistance and its Role in Cancer Metastasis (review)

Work Experience/Internship
08.2015-06.2016: Teaching Assistant, Chemistry and Epidemiology, Asian University for Women, Chittagong, Bangladesh
07.2013 -08.2013: Internship in Microbiology Lab and Immunology Lab, Paropakar Maternity and Women’s Hospital, Kathmandu, Nepal

Research Interest/Future Plans
Immunotherapy has been considered as one of the promising treatment methods for cancer. However, there are still many underlying mechanisms that need to be studied. Understanding how cancer cells overcome the immune checkpoints and examining deeper the immune-cancer relation is what I am very interested in. I also want to explore the ways to overcome immune tolerance. I hope to enrich my knowledge and understanding of cancer immunology, the current research techniques and drug development protocols. In the future I want to pursue a PhD in the field of cancer immunology.

Contact
j.pokharel (at) dkfz.de

Jan-Philipp QUAST (Germany)

© dkfz.de

University Education
10/2016 – present: Ruprecht-Karls-Universität Heidelberg and German Cancer Research Center (DKFZ, Heidelberg), MSc. Molecular Biosciences, Major Cancer Biology
10/2015 – 04/2016: Imperial College London, Department of Life Sciences, Biochemistry
10/2013 – 08/2016: Ruprecht-Karls-Universität Heidelberg, BSc. in Biosciences

Highest Degree
Bachelor of Science in Biosciences

Title of Bachelor Thesis
Analysis of the Architecture of Intermolecular Disulfide Bonds in Membrane-Inserted FGF2 Oligomers

Internships
01/2016 – 04/2016: Imperial College, Department of Life Sciences, Metabolism in Cancer, Group of Dr. David Mann
03/2015 – 04/2015: Ruprecht-Karls-Universität Heidelberg, Centre for Organismal Studies Heidelberg (COS), Developmental and Stem Cell Biology, Group of Prof. Jochen Wittbrodt
05/2011 – 06/2011: GATC Biotech, Konstanz, Provider for DNA Sequencing, Under the Guidance of Jochen Schaefer

Research Interest/Future Plans
My particular areas of interest in cancer biology are signal transduction and metabolism. The alterations in metabolic pathways, which are often found in cancerous cells, occur not only due to mutations, but also contribute to their establishment. These changes reduce or increase susceptibility to therapeutic intervention, depending on the type of cancer. The intensive study of metabolism in cancer cells has not only become more and more important since it was added to the list of hallmarks of cancer in 2011, but also because it offers new targets for successful therapies. I am sure that this Master programme will help me gain a deeper knowledge into cancer cell metabolism and the various other fields of cancer biology. Furthermore, the cutting-edge cancer research and unique environment of the DKFZ will help my aim to go on with a PhD and PostDoc thereafter.

Contact
j.quast (at) dkfz.de

Esther RODRÍGUEZ CORREA (Spain)

© dkfz.de

University Education
10/2016-present: Ruprecht-Karls-Universität Heidelberg and German Cancer Research Center (DKFZ, Heidelberg), MSc. Molecular Biosciences, Major Cancer Biology
09/2012-05/2016- Universidad Autónoma de Madrid, Faculty of Sciences (Madrid, Spain)

Highest Degree
B.Sc. in Biochemistry

Title of Bachelor Thesis
Role of IL-7 receptor SNPs in the physiopathology of T-acute lymphoblastic leukemia

Internships
01/2016-06/2016: Bachelor Thesis ‘Role of IL-7 receptor SNPs in the physiopathology of T-acute lymphoblastic leukemia’ in the group of Dr. Toribio, Department of Immunology and Cellular Biology, Center of Molecular Biology Severo Ochoa (CMBSO), Madrid, Spain
06/2015-08/2015: Summer Research Grant (Spanish Association Against Cancer, Spain) in the group of Dr. Vilar, Department of Molecular Neurobiology, Institute of Health Carlos III (ISCIII), Madrid, Spain. ‘Implication of TrkA mutations in the development of glioblastoma’
06/2014-08/2014: Summer Research Internship in the group of Dr. Mira, Department of Molecular Neurobiology, Institute of Health Carlos III (ISCIII), Madrid, Spain. ‘Neurogenesis’

Research Interest/Future Plans
During my Bachelor studies, I could learn some molecular aspects of cancer. I was fascinated by the ability of tumor cells to adapt any situation and avoid any possible danger. The huge negative impact that this disease has in the whole population is also an important reason why I feel interest in knowing about this topic. Furthermore, during my Bachelor Thesis in a lab of T-acute lymphoblastic leukemia, I discovered my interest in the implication of the immune system in cancer. I have chosen the Cancer Biology programme because it imparts a quality professional training, with current techniques and excellent researchers. During the programme, I would like to deepen my knowledge in the exciting issues mentioned and to be prepared for the PhD studies.

Contact
e.rodriguezcorrea (at) dkfz.de

Felix ROSEMANN (Germany)

© dkfz.de

University Ecuation
10/2016 - present: Master of Science (M.Sc.) in Molecular Biosciences (Major Cancer Biology) at Heidelberg University and DKFZ in Heidelberg, Germany
10/2012 - 07/2016: Bachelor of Science (B.Sc.) in Biosciences at Heidelberg University, Germany

Highest Degree
Bachelor of Science (B.Sc.) in Biosciences

Title of Bachelor Thesis
H3F3A mutation-specific knock out in GCTB stromal cells

Internships
08/2016 - present: Research assistant in the group of Prof. Plass, Division of Epigenomics and Cancer Risk Factors, DKFZ, Heidelberg, Germany
01/2016 - 07/2016: Internship and bachelor thesis in the group of Prof. Plass, Division of Epigenomics and Cancer Risk Factors, DKFZ, Heidelberg, Germany

Research Interest/Future Plans
In molecular biology, many different subjects appeal to me, however, for me epigenetics is the most interesting field. Regarding cancer, I am fascinated by how the interplay of genetic and epigenetic changes can lead to a widespread misregulation within the cell and thereby induce such a severe disease. I therefore want to continue to do research on this topic and contribute to our understanding of the mechanisms in cancer biology.

Contact
f.rosemann (at) dkfz.de

Maximilian SCHÖNUNG (Germany)

© dkfz.de

University Education
10/2013 - 09/2016: Bachelor of Science in Biology, Ludwig-Maximilians-Universität München, Germany
10/2016 - present: Master of Science in Molecular Biosciences – Major Cancer Biology, Ruprecht-Karls-Universität Heidelberg and German Cancer Research Center (DKFZ), Germany

Highest Degree
Bachelor of Science (BSc) in Biology

Title of Bachelor Thesis
Generation of TET triple knockout mouse embryonic stem cells using CRISPR/Cas9

Scholarship
Max Weber-Program of the State of Bavaria

Research Experience
05/2015 - 06/2016: Research Assistant “AG Nickelsen”, Ludwig-Maximilians-Universität München, Germany
04/2016 - 07/2016: Bachelor Thesis „AG Leonhardt“, Dr. Sebastian Bultmann, Ludwig-Maximilians-Universität München, Germany

Research Interest/Future Plans
Cancer development is multistep process that is promoted by genetic and epigenetic alterations. Basic research of pathways that maintain stem cell pluripotency or introduce lineage differentiation is important to understand this complex disease. I am especially interested in epigenetic research of DNA methylation and hydroxymethylation during stem cell differentiation, development and tumorigenesis. The role of DNA modifications like 5-hydroxymethylcytosine as distinct epigenetic marks is just emerging and it will be challenging to assess their functions for gene regulation and cancer development.  Furthermore one of my main interests is the potential of genomic engineering in the fields of epigenetics and gene regulation. Powerful tools like CRISPR/Cas9 offer us a possibility to specifically introduce epigenetic modifications and investigate their role during cancerogenesis. This enables research of pathways related to a stem cell state and reprogramming of cancer stem cells, promising a better understanding of cancer and advanced therapies for tumor patients.      

Contact
m.schoenung (at) dkfz.de

Nardine SOLIMAN (Egypt)

© dkfz.de

University Education
10/2016 - present: MSc. in Molecular Biosciences with major Cancer Biology, Ruprecht-Karls-Universität Heidelberg and DKFZ, Heidelberg, Germany
10/2011 - 07/2016: BSc. in Pharmacy and Biotechnology, German University in Cairo (GUC), Cairo, Egypt
 
Highest Degree
BSc. in Pharmacy and Biotechnology with highest honours

Internships
02/2014: “DNA extraction from different genetic models”, internship at Ain Shams Center of Genetic Engineering and Biotechnology, Cairo, Egypt
06/2014 - 07/2014: “Design and synthesis of novel inhibitors of c-Jun N-terminal kinase 3”, visiting student at the research group of Dr. Pierre Koch, Department of Pharmacy and Biochemistry, Institute of Pharmaceutical Sciences, Eberhard Karls University of Tübingen, Germany
08/2014: Summer Internship at the Viral and Zoonotic Diseases Research department, U.S. Naval Medical Research Unit No.3 (NAMRU-3), Cairo, Egypt
07/2015 - 08/2015: “Glycosyltransferases from Actinomycetes”, visiting student at the research group of Prof. Dr. Andreas Bechthold, Institute of Pharmaceutical Biology and Biotechnology, Albert-Ludwigs University of Freiburg, Germany

Research Interest/Future Plans
My pharmaceutical background has driven my scientific focus towards anti- cancer drug discovery. Translational oncology and individualized cancer therapy are also particularly intriguing fields for me. I believe that a strong understanding of the disease itself is the key step towards the discovery of novel therapies. Many mechanisms underlying cancer initiation and progression still need to be demystified. One of the mysteries to be unlocked is how the immune system is engaged within the tumor microenvironment. When suppressed, immunity constitutes a driving force for tumor progression, while in other contexts; immunity can be used to fight and even treat cancer as in immunotherapy. I am confident that the exceptional scientific milieu that the DKFZ provides, will allow me to acquire a robust theoretical knowledge as well as to receive advanced hands-on experience, which will thereafter pave my career path in the field of cancer research.
 
Contact
n.soliman (at) dkfz.de

Maja STAROSTECKA (Poland)

© dkfz.de

University Education
10/2016 - present: Pursuing MSc in ‘Molecular Biosciences with Major Cancer Biology’, Heidelberg University and DKFZ, Germany
10/2012 - 01/2016: BSc in Biotechnology, Wroclaw University of Technology, Faculty of Chemistry, Poland

Highest Degree
BSc in Biotechnology

Title of Bachelor Thesis
Influence of vitamin D analogs on the antitumor activity of 5-fluorouracil against 5-fluorouracil sensitive and resistant human colon cancer cell line HT-29

Internships
02/2016 - 06/2016: volunteer research assistant within Helmholtz University Junior Research Group Vascular Signaling and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
10/2013 – 01/2016: volunteer research undergraduate assistant in Laboratory of Experimental Anticancer Therapy, Institute of Immunology and Experimental Therapy, Polish Academy of Science, Wroclaw, Poland
07/2014 – 09/2014: summer scholarship in Department of Molecular Cell Biology, Institute of Cancer Research at The Norwegian Radium Hospital, Centre for Cancer Biomedicine, Oslo University Hospital, Norway
07/2013: volunteer research undergraduate assistant in the Department of Bioorganic Chemistry, Wroclaw University of Technology, Poland

Research Interest/Future Plans
Tumor heterogeneity is one of the challenges that researchers need to address. A huge amount of generated data has to be analysed properly, so that cancer patients could be treated successfully. Being fascinated by complexity of signaling pathways, I would like in the future to focus on translational oncology, especially target identification and validation in drug discovery. I do hope that owing to this Master program I will obtain excellent preparation for further PhD studies.

Contact
m.starostecka (at) dkfz.de

Kristin STIRM (Germany)

© dkfz.de

University Education
10/2016 - present: M.Sc. in Molecular Biosciences with Major Cancer Biology, Ruprecht-Karls-University Heidelberg and German Cancer Research Center (DKFZ), Germany
09/2012 - 03/2016: B.Sc. in Biomedical Sciences, Reutlingen University, Germany

Highest Degree
B.Sc. in Biomedical Sciences

Title of Bachelor Thesis
Affinity proteomics analysis of ovarian cancer tissue and plasma using DigiWest

Apprenticeship
09/2009 - 07/2011: Environmental Technical Assistant, Kerschensteinerschule Stuttgart-Feuerbach, Germany

Internships
03/2016 - 09/2016: Internship at Roche Diagnostics GmbH Penzberg, Germany, Department of Immunobiology, Dr. Königsberger
09/2015 - 03/2016: Erasmus+ - supported internship and Bachelor thesis at Science for Life Laboratory (SciLifeLab) Stockholm, Sweden, Department of Affinity Proteomics, Dr. Schwenk
09/2014 - 09/2015: Internship and HiWi at Natural and Medical Sciences Institute (NMI) at the University of Tübingen, Germany, Department of Biochemistry, Dr. Templin

Research Interests/Future Plans
During my diversified bachelor studies of Biomedical Sciences, I have discovered my commitment for cancer biology focusing on immune oncology. Within this research field I am fascinated especially by the molecular and cellular mechanisms of interaction between the immune system and cancer cells. Moreover, oncolytic viruses with its huge potential as a tool fighting cancer captured my attention. I am eager to broaden my knowledge about the hallmarks of cancer and the way those can be affected by immune therapies to turn the immune system back on to fight against cancer. Furthermore, for me it is such an important point that one in two or three carcinomas could be prevented by environmental and life-style related aspects and early screenings. Thus, studies of cancer risk factors and the mechanisms of prevention substances comprises my concern. My future plans are to contribute to a better understanding of tumorigenesis to improve prevention, early detection and personalized treatment regimen. I choose this major “Cancer Biology” since it imparts a solid training using current methods at the cutting-edge, to be best prepared for a PhD program afterwards.

Contact
k.stirm (at) dkfz.de

Mirjam STRANZL (Austria)

© dkfz.de

University Education
2016 – present: Master of Science in Molecular Biosciences, Major Cancer Biology, Ruprecht - Karls University Heidelberg and DKFZ, Germany
2013 – 2016: Bachelor of Science and Engineering in Medical and Pharmaceutical Biotechnology, IMC University of applied Sciences Krems, Austria
2012 – 2013 (1st semester): School of law, Ludwig Maximilian University of Munich (LMU), Germany
 
Highest Degree
Bachelor of Science and Engineering in Medical and Pharmaceutical Biotechnology
 
Title of Bachelor Thesis
“Discovery of novel HES1 transcriptional targets in leukemic cells” - Targeting the Notch/HES1 signaling axis - a novel treatment approach for AML
 
Bachelor Paper I
“The Roles of Genetics and Epigenetics in Acute Myeloid Leukemia (AML)” - Recent findings in acute myeloid leukemogenesis and subsequent changes in classification, prognosis and treatment

Internship
August 2015 – January 2016: Molecular Medicine Research Unit, Cancer Campus Gustave Roussy, Paris, France (Labgroup. Camille Lobry, PhD.)

Research Interest/Future Plans
Cancer biology has especially caught my curiosity and interest since the subject not only focuses on one specific disease but has a broad spectrum of clinical phenotypes which require different treatments. This interest in oncology and passion for molecular research was enhanced during my internship on the Cancer campus IGR in Paris, where I studied the tumor suppressive Notch2/Hes1 signaling axis in acute myeloid leukemia (AML). Furthermore, I want to understand underlying triggers of cancer to be able to help improve the living conditions and elongating the survival time of cancer patients with modern and personalized treatment. This is only possible with a profound education and experience. I am convinced that the University of Heidelberg and the DKFZ in their position at the cutting edge of international cancer research provide the best basis to achieve these goals and also for my intention to pursue a PhD program.

Contact
m.stranzl (at) dkfz.de

Sören STROHMENGER (Germany)

© dkfz.de

University Education
10/2016 - present: M.Sc. in Molecular Biosciences with Major Cancer Biology, Ruprecht-Karls University Heidelberg and DKFZ
10/2013 - 07/2016: B.Sc. in Biomedical Science, Philipps University Marburg

Highest Degree
Bachelor of Science in Biomedical Science

Title of Bachelor Thesis
HPRT1 as selectable marker for CRISPR/Cas9 induced homology-directed repair

Internships
02/2016 - 07/2016 Bachelor Thesis at the Institute of Molecular Biology and Tumor Research, Stiewe group, Philipps University Marburg
08/2015 - 09/2015 Internship at the Department of Chemistry, Pamme group, University of Hull, UK

Research Interests/Future Plans
I am fascinated by how the intricate interplay of small mutations in tumour suppressor genes and oncogenes, together with environmental influences, can lead to the development of cancer. I believe basic research is very important to lead the way to possible new cancer therapies in the future. Especially in the fields of signalling pathways and inflammatory tumour microenvironment there is still a lot that remains unknown. With this Masters programme I hope to deepen my knowledge in these topics as well as other aspects of tumour biology and to be prepared for a future career in cancer research.

Contact
s.strohmenger (at) dkfz.de

to top